MLAB MESA LABORATORIES INC /CO/
Industrial Instruments For Measurement, Display, and Control · Nasdaq · SEC CIK 724004 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY2.5%
TTM net income YoY524.0%
TTM EPS YoY474.2%
Revenue 3-yr CAGR5.6%
Net income 3-yr CAGR—
Margins
Gross margin64.8%
Operating margin10.4%
Net margin2.7%
FCF margin19.7%
EBITDA margin12.4%
Returns
ROE3.6%
ROA1.6%
ROIC (approx.)5.6%
Asset turnover0.60x
Leverage & solvency
Liabilities / assets52.3%
Debt / equity0.33x
Current ratio1.90x
Interest coverage2.58x
Cash quality & payout
Operating cash flow / net income7.73x
Accruals ratio-10.7%
Payout ratio53.3%
Capex / revenue0.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q22026-09-30 | 2027Q12026-06-30 | 2026Q4*2026-03-31 | 2025Q32025-12-31 | 2025Q22025-09-30 | 2025Q12025-06-30 | 2025Q4*2025-03-31 | 2025Q32024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $62.34M | $60.14M | $63.72M | $65.13M | $60.74M | $59.54M | $62.13M | $62.84M |
| Cost of revenue | $22.46M | $21.13M | $21.52M | $23.33M | $23.41M | $22.60M | $23.72M | $23.09M |
| Gross profit | $39.88M | $39.01M | $42.20M | $41.80M | $37.33M | $36.94M | $38.41M | $39.75M |
| R&D expense | $5.05M | $4.72M | $5.25M | $5.03M | $5.05M | $4.98M | $5.10M | $5.05M |
| SG&A expense | $16.61M | $17.38M | $24.13M | $18.80M | $17.76M | $17.96M | $20.58M | $18.47M |
| Operating income | $8.39M | $7.03M | $2.75M | $7.97M | $4.72M | $3.06M | $1.47M | $5.78M |
| Interest expense | $2.14M | $2.36M | $2.60M | $3.04M | $2.86M | $2.20M | $2.52M | $2.84M |
| Pretax income | $6.03M | $4.35M | -$1.59M | $4.60M | $2.00M | $7.01M | $461,000 | -$2.22M |
| Income tax | $1.69M | $1.52M | $2.54M | $966,000 | -$477,000 | $2.27M | $7.58M | -$541,000 |
| Net income | $4.34M | $2.83M | -$4.14M | $3.63M | $2.48M | $4.74M | -$7.11M | -$1.68M |
| EBITDA | $9.64M | $8.28M | $4.01M | $9.24M | $6.04M | $4.47M | $2.82M | $6.88M |
| EPS (basic) | 0.77 | 0.50 | — | 0.66 | 0.45 | 0.87 | — | -0.31 |
| EPS (diluted) | 0.75 | 0.49 | — | 0.65 | 0.45 | 0.85 | — | -0.31 |
| Dividends declared per share | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Weighted avg. shares (diluted) | 5.76M | 5.76M | — | 5.57M | 5.54M | 5.55M | — | 5.43M |
| Balance sheet | ||||||||
| Cash & equivalents | $22.31M | $30.70M | $26.93M | $28.98M | $20.42M | $21.28M | $27.32M | $27.32M |
| Receivables | $39.38M | $34.41M | $44.10M | $40.23M | $40.09M | $39.07M | $41.97M | $41.97M |
| Inventory | $26.55M | $27.23M | $26.37M | $26.56M | $27.74M | $28.11M | $25.36M | $25.36M |
| Current assets | $98.25M | $102.85M | $106.27M | $105.63M | $97.43M | $98.26M | $102.69M | $102.69M |
| PP&E, net | $29.34M | $30.09M | $30.61M | $31.60M | $31.84M | $31.69M | $32.33M | $32.33M |
| Goodwill | $185.24M | $186.86M | $186.86M | $189.30M | $188.49M | $188.05M | $181.76M | $181.76M |
| Intangibles | $73.51M | $78.40M | $83.35M | $89.65M | $93.27M | $97.40M | $96.88M | $98.18M |
| Total assets | $407.74M | $419.22M | $427.75M | $434.85M | $430.35M | $435.74M | $433.35M | $433.35M |
| Current liabilities | $51.58M | $57.32M | $61.90M | $54.40M | $48.30M | $149.49M | $163.96M | $163.96M |
| Long-term debt | $64.69M | $66.09M | $67.50M | $68.44M | $69.38M | $70.31M | $71.25M | $72.19M |
| Total debt | $64.69M | $66.09M | $67.50M | $68.44M | $69.38M | $70.31M | $71.25M | $72.19M |
| Total liabilities | $213.14M | $230.46M | $241.50M | $248.16M | $251.88M | $263.25M | $273.52M | $273.52M |
| Shareholders' equity | $194.60M | $188.76M | $186.25M | $186.69M | $178.47M | $172.50M | $159.83M | $155.21M |
| Net debt | $42.38M | $35.40M | $40.57M | $39.46M | $48.95M | $49.03M | $43.93M | $44.87M |
| Shares outstanding | 5.61M | 5.60M | 5.52M | 5.52M | 5.51M | 5.50M | 5.46M | 5.46M |
| Cash flow statement | ||||||||
| Operating cash flow | $4.10M | $14.74M | $13.96M | $18.75M | $8.22M | $1.89M | $12.66M | $18.44M |
| Capital expenditure | $387,000 | $559,000 | $417,000 | $732,000 | $1.09M | $1.01M | $757,000 | $813,000 |
| Free cash flow | $3.71M | $14.18M | $13.54M | $18.02M | $7.13M | $884,000 | $11.91M | $17.63M |
| Investing cash flow | -$387,000 | -$559,000 | -$417,000 | -$732,000 | -$1.09M | -$1.01M | -$1.01M | -$813,000 |
| Financing cash flow | -$12.31M | -$10.50M | -$15.76M | -$9.79M | -$7.88M | -$8.43M | -$16.19M | -$10.60M |
| Depreciation & amortization | $1.25M | $1.25M | $1.26M | $1.27M | $1.31M | $1.40M | $1.35M | $1.11M |
| Stock-based compensation | $3.38M | $2.36M | $6.79M | $3.38M | $3.81M | $3.88M | $3.14M | $3.24M |
| Dividends paid | $898,000 | $884,000 | $884,000 | $884,000 | $882,000 | $873,000 | $870,000 | $869,000 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.